1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with evans blue in 6 studies
Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (evans blue) | Trials (evans blue) | Recent Studies (post-2010) (evans blue) |
---|---|---|---|---|---|
195 | 3 | 161 | 2,119 | 12 | 405 |
Protein | Taxonomy | 1,4,7-triazacyclononane-n,n',n''-triacetic acid (IC50) | evans blue (IC50) |
---|---|---|---|
Luciferin 4-monooxygenase | Photinus pyralis (common eastern firefly) | 5.4 | |
60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 0.17 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 1.3 | |
Tyrosine-protein phosphatase 1 | Saccharomyces cerevisiae S288C | 1.2 | |
10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 0.17 | |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Homo sapiens (human) | 0.922 | |
Thiosulfate sulfurtransferase | Homo sapiens (human) | 8.7 | |
60 kDa chaperonin | Escherichia coli | 0.063 | |
10 kDa chaperonin | Escherichia coli | 0.063 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Ali, IU; Chen, X; Huang, P; Jacobson, O; Kiesewetter, DO; Lang, L; Niu, G; Teng, G; Wang, Y; Wang, Z | 1 |
Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Lang, L; Liu, Y; Ma, Y; Niu, G; Wang, G; Wu, H; Zhang, X; Zhu, L | 1 |
Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Liu, Y; Ma, Y; Niu, G; Weiss, ID; Wu, H | 1 |
Bai, R; Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Lang, L; Ma, Y; Niu, G; Tong, X; Wu, H; Yang, X; Yung, BC | 1 |
Chen, X; Cheng, W; Hou, B; Hou, G; Jiang, Y; Long, X; Zhu, Z | 1 |
Chen, X; Cheng, W; Hou, G; Jiang, Y; Li, F; Xu, KF; Xu, W | 1 |
6 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and evans blue
Article | Year |
---|---|
In vivo albumin labeling and lymphatic imaging.
Topics: Albumins; Aluminum Compounds; Animals; Diagnostic Imaging; Evans Blue; Fluorescence; Fluorides; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Hindlimb; Image Processing, Computer-Assisted; Inflammation; Luminescent Measurements; Lymph Nodes; Lymphatic Vessels; Mice, Inbred BALB C; Multimodal Imaging; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Staining and Labeling | 2015 |
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding.
Topics: Albumins; Animals; Cell Line, Tumor; Copper Radioisotopes; Evans Blue; Exenatide; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Venoms | 2016 |
Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Evans Blue; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Oligopeptides; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Tissue Distribution; Yttrium Radioisotopes | 2017 |
Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography.
Topics: Animals; Antineoplastic Agents; Bevacizumab; Blood Volume; Capillary Permeability; Carcinoma; Disease Models, Animal; Evans Blue; Fluorine Radioisotopes; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Insulinoma; Positron-Emission Tomography; Rats | 2017 |
68Ga-NOTA-Evans Blue TOF PET/MR Lymphoscintigraphy Evaluation of the Severity of Lower Limb Lymphedema.
Topics: Adult; Evans Blue; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lower Extremity; Lymphatic Vessels; Lymphedema; Lymphoscintigraphy; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography | 2019 |
Lymphangioleiomyomatosis revealed by
Topics: Evans Blue; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Lymphangioleiomyomatosis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |